Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03054584 · ClinicalTrials.gov registry record
Genetic Basis of Melanocytic Nevi
A clinical trial of Melanocytic Nevi, sponsored by University of California, Davis.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT03054584: Recruiting study of Melanocytic Nevi, sponsored by University of California, Davis.
NCT03054584 is a study of Melanocytic Nevi that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03054584, a study of Melanocytic Nevi, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this protocol is to further elucidate the genetic mutations that drive melanocytic nevi (benign melanocytic neoplasms, moles). This will be performed by whole genome, whole exome, or targeted sequencing of de-identified specimens. Herein, the investigators plan to isolate DNA from de-identified skin biopsy specimens and blood samples: 1. From melanocytic nevi collected by skin biopsy (a shave or punch biopsy). A part of the tissue will be submitted for routine diagnostic dermatopathology and investigational histomorphologic and immunohistochemical analysis. 2. From corresponding normal tissue (blood). DNA isolated from blood will be used as a normal control when analyzing sequencing data to identify somatic mutations in lesional tissue.
Primary Outcome
Will be performing genome wide mutation analysis to quantify the number of mutations.
Conditions Studied
Interventions
- OTHER Collecting Nevi
Study Locations (1)
California
- University of California-Davis, Department of Dermatology - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-06-26 |
| Est. Completion | 2028-06 |
What NCT03054584 shows while recruiting
NCT03054584 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 1 condition, with Melanocytic Nevi appearing as the primary indexed condition, and to 1 intervention - of which Collecting Nevi is the first listed.
NCT03054584 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03054584 about?
NCT03054584 is a clinical study titled "Genetic Basis of Melanocytic Nevi". The objective of this protocol is to further elucidate the genetic mutations that drive melanocytic nevi (benign melanocytic neoplasms, moles). This will be performed by whole genome, whole exome, or targeted sequencing of de-identified specimens. Herein, the investigators plan to isolate DNA from ...
What is the current status of trial NCT03054584?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2017-06-26. Estimated completion is 2028-06.
What conditions does trial NCT03054584 study?
This clinical trial studies the following conditions: Melanocytic Nevi.
What interventions are being tested in trial NCT03054584?
The interventions under investigation include: Collecting Nevi (OTHER).
Who is sponsoring clinical trial NCT03054584?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03054584 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI